Prof. Amiji’s Corner
- Prof. Amiji’s thoughts on the impact of budget slashes from the federal government on scientific research
- Prof. Amiji’s interview published in the November issue of newsletter from Control Release Society (CRS).
- Prof. Amiji receives the 2012 Nagai Award from the Controlled Release Society (CRS).
- Targeting tumors with Nanotechnology-news@NEU
- Prof. Amiji joins the team of Nemucore Medical Innovations, Inc as Founder and Scientific Advisory Board member.
- i-newswire covers our new work direction with Nemucore Medical Innovations, Inc.
- 3Q’s: From drug development to treating disease
- Toning down cancer’s aggressiveness
- Drug-delivery research shows early promise
- IGERT Nanomedicine
- Drug delivery research @ NEU
- Oral gene delivery system works, Prof. Amiji’s word
- Prof. Amiji joins the Editorial Board of Drug Design, Development and Therapy
- Prof. Amiji’s active involvement in NSTI-Nanotech Symposium 2009, 2011
- Some of our research works
- Nanotechwire.com covers our reseach on overcoming drug resistance
- Prof. Amiji’s interview
- Pharmaceutics meets nanotech
Group Member’s Corner
- Arun has received the 2012 Nagai Award from the Controlled Release Society (CRS).
- Jing Xu receives the 2012 John L. Neumeyer research achievement award.
- Jing Xu Receives Two American Association of Pharmaceutical Scientists (AAPS) Awards
- Shardool Jain Receives Two Prestigious Awards at the 2010 American Association of Pharmaceutical Scientists (AAPS) National Meeting
- IGERT Fellow, Padmaja Magadala, Wins ISPE Poster Competition
- IGERT Nanomedicine Fellow wins AAPS-NERDG Academic Research Award
- Online publication video featuring Jing Xu embedjove.php?id=3612
- CT scan of rat induced with arthritis
- Qualitative evaluation of arthritis in male Lewis rats via MRI-forelimbs
- Qualitative evaluation of arthritis in male Lewis rats via MRI-hindlimbs
- Shardool’s beam walk experiment :Combined Video Sequence showing the animal mobility profile of the control and macrophage targeted nanoparticles, containing IL-10 plasmid DNA, upon administration in male Lewis rats at day 17, post-arthritis induction. (A) Naïve Rat (No Arthritis), (B) Arthritic Rat-No Treatment, (C) Scrambled-peptide modified nanoparticle treatment, (D). Tuftsin-peptide modified nanoparticle treatment. The tests revealed that tuftsin-peptide nanoparticle treatment led to complete alleviation in inflammation. As a result these animals were able to traverse the entire length of the beam in about 3 seconds whereas the arthritic animals (without treatment) and scrambled modified nanoparticle treated rats struggled to balance themselves on the beam”